These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30300713)

  • 1. Association networks in a matched case-control design - Co-occurrence patterns of preexisting chronic medical conditions in patients with major depression versus their matched controls.
    Kim MH; Banerjee S; Zhao Y; Wang F; Zhang Y; Zhu Y; DeFerio J; Evans L; Park SM; Pathak J
    J Biomed Inform; 2018 Nov; 87():88-95. PubMed ID: 30300713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the impact of chronic conditions on a diagnosis of major depressive disorder in adults: a cohort study using linked electronic medical records.
    Ryu E; Chamberlain AM; Pendegraft RS; Petterson TM; Bobo WV; Pathak J
    BMC Psychiatry; 2016 Apr; 16():114. PubMed ID: 27112538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: A longitudinal study based on 4.7 million adults in South Korea.
    Han KM; Kim MS; Kim A; Paik JW; Lee J; Ham BJ
    J Affect Disord; 2019 Oct; 257():486-494. PubMed ID: 31319340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly diagnosed major depressive disorder and the risk of erectile dysfunction: a population-based cohort study in Taiwan.
    Huang SS; Lin CH; Chan CH; Loh el-W; Lan TH
    Psychiatry Res; 2013 Dec; 210(2):601-6. PubMed ID: 23850431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.
    Yates WR; Mitchell J; Rush AJ; Trivedi MH; Wisniewski SR; Warden D; Hauger RB; Fava M; Gaynes BN; Husain MM; Bryan C
    Gen Hosp Psychiatry; 2004; 26(6):421-9. PubMed ID: 15567207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases prevalent before major depressive disorder diagnosis: an exploratory nested case-control study using health insurance-based claims data.
    Cho Y; Mishiro I; Akaki T; Akimoto T; Fujikawa K
    BMJ Open; 2022 Feb; 12(2):e048233. PubMed ID: 35168961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Suicide in Patients With Major Depressive Disorder and Comorbid Chronic Pain Disorder: An Insight From National Inpatient Sample Data.
    Jolly T; Vadukapuram R; Trivedi C; Mansuri Z; Adnan M; Cohen SP; Vu TN
    Pain Physician; 2022 Sep; 25(6):419-425. PubMed ID: 36122252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between neighborhood socioeconomic status and healthcare utilization among individuals with a first diagnosis of major depressive disorder in primary care in the Stockholm region.
    Gannedahl A; Björkholm C; Leval A; Cars T; Hellner C; Lundberg J
    J Affect Disord; 2024 Oct; 362():96-103. PubMed ID: 38914164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions.
    Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
    J Manag Care Spec Pharm; 2020 Aug; 26(8):996-1007. PubMed ID: 32552362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of developing major depressive disorder in polycystic ovary syndrome: a retrospective cohort study.
    Lee IO; Kim JC; Seo JW; Pak HY; Chung JE
    J Obstet Gynaecol; 2021 Oct; 41(7):1157-1161. PubMed ID: 33645403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study.
    Li CT; Bai YM; Tu PC; Lee YC; Huang YL; Chen TJ; Chang WH; Su TP
    PLoS One; 2012; 7(10):e46818. PubMed ID: 23056466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder.
    Alpert JE; Fava M; Uebelacker LA; Nierenberg AA; Pava JA; Worthington JJ; Rosenbaum JF
    Biol Psychiatry; 1999 Jul; 46(2):202-11. PubMed ID: 10418695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata.
    Vallerand IA; Lewinson RT; Parsons LM; Hardin J; Haber RM; Lowerison MW; Barnabe C; Patten SB
    JAMA Dermatol; 2019 Apr; 155(4):475-479. PubMed ID: 30649133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of Additional Psychiatric Disorders in Severe Depression/Melancholia: A Comparison between Suicides and Controls and General Pattern.
    Heu U; Bogren M; Wang AG; Brådvik L
    Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29933593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
    Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
    J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States.
    Pizzicato LN; Xie RZ; Yang Y; Grabner M; Chapman RH
    J Manag Care Spec Pharm; 2023 Jun; 29(6):614-625. PubMed ID: 37276037
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review.
    Shon SH; Joo Y; Park J; Youngstrom EA; Kim HW
    Eur Child Adolesc Psychiatry; 2014 May; 23(5):307-16. PubMed ID: 23963644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.